UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000019648
Receipt No. R000022706
Official scientific title of the study Tracheal intubating conditions using sevoflurane and remifentanil target-controlled infusions without muscle relaxant.
Date of disclosure of the study information 2015/11/05
Last modified on 2016/04/11 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Tracheal intubating conditions using sevoflurane and remifentanil target-controlled infusions without muscle relaxant.
Title of the study (Brief title) tracheal intubating conditions with remifentanil TCI.
Region
Japan

Condition
Condition otological patients without muscle relaxant
Classification by specialty
Oto-rhino-laryngology Anesthesiology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We aimed to determine the most appropriate dose of remifentanil required for intubation using target -controlled infusion(TCI).
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Intubating score
Blood pressure, heart rate of intubation
Dose of vasopressor agent
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Dose comparison
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking
Concealment

Intervention
No. of arms 3
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 remifentanil TCI 15 ng/ml(effect site concentration)
Interventions/Control_2 remifentanil TCI 10 ng/ml(effect site concentration)
Interventions/Control_3 remifentanil TCI 5 ng/ml(effect site concentration)
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria otological patients without muscle relaxant
Key exclusion criteria
Patients who refuse to participate this study

Patients who have severe cardiovascular disease
Target sample size 60

Research contact person
Name of lead principal investigator Manabu Yoshimura
Organization Tokuyama Central Hospital
Division name Department of anesthesiology
Address 1-1 Kodaco, Shunan-city 745-0825
TEL 0834-22-4411
Email manabu-ygc@umin.ac.jp

Public contact
Name of contact person Manabu Yoshimura
Organization Tokuyama Central Hospital
Division name Department of Anesthesiology
Address 1-1 Kodacyo, Shunan-city
TEL 0834-22-4411
Homepage URL
Email manabu-ygc@umin.ac.jp

Sponsor
Institute Tokuyama Central Hospital
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization Tokuyama Central Hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions JCHO徳山中央病院(山口県)

Other administrative information
Date of disclosure of the study information
2015 Year 11 Month 05 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 11 Month 05 Day
Anticipated trial start date
2015 Year 11 Month 05 Day
Last follow-up date
2016 Year 04 Month 01 Day
Date of closure to data entry
2016 Year 04 Month 01 Day
Date trial data considered complete
2016 Year 04 Month 01 Day
Date analysis concluded
2016 Year 04 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 11 Month 05 Day
Last modified on
2016 Year 04 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000022706